(Q50990539)
Statements
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint (English)
Rachel A McGovern
P Richard Harrigan
Steven F L van Lelyveld
Andy I M Hoepelman
Petra M van Ham
Winnie Dong
Annemarie M J Wensing